People | February 22, 2022
PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
US $ 555,000 invested by Wavemaker Partners in pre-seed round
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida
Daewoong delivered KRW 1.055 trillion in sales, KRW 95.5 billion in operating profit and KRW 40.5 billion in net profit.
Revotek announced that it has received clearance from the National Health Commission of China to begin a clinical study in the West China Hospital, Chengdu, with its first stem cell 3D bioprinting product, REVOVAS.
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
The facility will manufacture its Herceptin biosimilar, Tuznue
Subscribe To Our Newsletter & Stay Updated
